You are not connected
23
1
NovaHep AB
Company
|
Sweden
Primary tabs
About your organization
NovaHep generates personalized tissue-engineered transplants for use in regenerative medicine. The company’s unique technology platform turns donated allogeneic (“foreign”) tissue into an autologous (“personalized”) tissue and thus avoids transplant rejection and the need for life-long immunosuppression. Donated, allogenic tissue is patient-individualized by a combination of DC (Decellularization) and RC (Reconditioning/Recellularization) processes. NovaHep’s development pipeline comprises products in the areas of vascular regeneration and peripheral nerve repair.
Network (0)
There are no organizations in the network.